Abstract:To die or not to die—that is the question. Up to date, there is accumulating evidence that in addition to necrosis, the programmed cell death plays a significant role in acute or delayed neuronal death in the central nervous system (CNS) disorders, such as neurodegenerative diseases and ischemic stroke. After focusing on necrosis and apoptosis as the major causes of neuronal death in the CNS disorders for dozens of years, it has been recognized that elaborating the mechanisms underlying neuronal death is not as easy as it looks. In recent years, autophagy has become one of the most attractive topics in the research of neuronal death of CNS disorders. The term autophagy comes from the Greek roots “auto” (self) and “phagy” (eating) and means selfdigestion. Previously, autophagy has been viewed as type II programmed cell death with a random process because it appears to engulf cytosol indiscriminately; however, it is now recognized as a tightly regulated endogenous biological response to degrade damaged and dysfunctional cellular organelles and protein aggregates. In neuronal cells, approximately 1% of cellular proteins are catabolized per hour by autophagy, even under nutrient-rich condition. Although it is not fully understood how much the basal autophagy contributes to macromolecule synthesis and energy production in the steady state by supplying amino acids, glucose, and free fatty acids, the role of basal autophagy acting as the quality-control machinery for cytoplasmic components is widely accepted [1]. Many neurodegenerative disorders, such as Parkinson disease (PD) and Alzheimer’s disease (AD), result from proteins that increase their propensity to form aggregates. While autophagy can eliminate aggregated proteins, defective mitochondria, and excessive reactive oxygen species (ROS) that could induce DNA damage and cell death, inadequate or defective autophagy promotes neuronal cell death in most of neurodegenerative disorders. It is becoming increasingly evident that the cell response may shift gradually from elimination of damaged proteins/organelles by autophagy, which leads to its recovery, to the induction of apoptotic or necrotic pathways determining cellular demise under both neurodegenerative disorders and brain ischemia (Figure 1). p62, a hot topic in cell death research in recent years, is a scaffolding protein that binds to polyubiquitin and associated with the nuclear envelope. Previous works reveal that p62 acts as a signaling hub through its ability to recruit and oligomerize important signaling molecules in cytosolic speckles to control cell apoptosis [2]. Thus, p62 is thought to be a detrimental player in the cell life [2]. However, this opinion is being challenged. Recently, p62 was found to be localized to autophagic compartments via preferential binding with LC3-II form, which may assist in removal of cellular proteins damaged by dopaminergic neurotoxin [3] and is involved in the decrease of the neuronal cell number under hypoxic stress [4]. p62 was also reported to be a potential diagnostic tool for Alzheimer’s disease [5]. Further, p62 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria in the pathogenesis of Parkinson’s disease [6–9], although there are minor disputes regarding the detailed mechanisms underlying the effect of p62 on the dysfunctional mitochondrial clustering and mitophagy [6–9]. Thus, whether p62 is a detrimental or a beneficial factor for the survival of neuronal cell depends on the pathological insults and the tissue microenvironment and the switch between autophagy and apoptosis, which is regulated by p62. Autophagy also participates in the cerebral ischemia-induced injury. Accumulating data supported the critical role of autophagy in cerebral ischemia as well as in neurodegenerative diseases [10 –12]. Nevertheless, autophagy may be a double-edged sword for cerebral ischemia [10–12]. We recently reviewed the beneficial and harmful effects of autophagy in cerebral ischemia [13]. In this issue of CNS Neuroscience & Therapeutics, Qi et al. describe a new role for Akt/glycogen synthase kinase 3b (GSK-3b)-dependent

Neuronal autosis is Na + /K + -ATPase alpha 3-dependent and involved in hypoxic-ischemic neuronal death

The role of neuronal autophagy in hypoxic-ischemic brain injiny

Autophagy in the Disorders of Central Nervous System: Vital And/or Fatal?

Death and Survival of Neuronal and Astrocytic Cells in Ischemic Brain Injury: A Role of Autophagy

Autophagy in neonatal hypoxia ischemic brain is associated with oxidative stress

Neuronal Injury in Rat Model of Permanent Focal Cerebral Ischemia is Associated with Activation of Autophagic and Lysosomal Pathways.

Role Of Autophagy In Neurite Degeneration In Vitro

Autophagy in Axonal and Dendritic Degeneration

Hypoxia-induced autophagy: cell death or cell survival?

NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency

Enhanced autophagy contributes to excitotoxic lesions in a rat model of preterm brain injury

The Role of Autophagy in Neuronal Ischemic Injury and Its Relationship with Apoptosis and Necrosis

Autophagy Activation is Associated with Neuroprotection Against Apoptosis Via a Mitochondrial Pathway in a Rat Model of Subarachnoid Hemorrhage

The role of lysosomal rupture in neuronal death

Autosis: a new form of cell death in myocardial ischemia–reperfusion injury

Autophagy–lysosomal-associated neuronal death in neurodegenerative disease

Oxygen-Glucose-Deprivation/Reoxygenation-Induced Autophagic Cell Death Depends on JNK-Mediated Phosphorylation of Bcl-2

Neuronal Autophagy: Characteristic Features and Roles in Neuronal Pathophysiology

Somatic Autophagy of Axonal Mitochondria in Ischemic Neurons

Role of autophagy in apoptosis in cortical neurons of rats in early phase of oxygen-glucose deprivation

Impaired autophagosome clearance contributes to neuronal death in a piglet model of neonatal hypoxic-ischemic encephalopathy